Reaction Details |
| Report a problem with these data |
Target | Mitogen-activated protein kinase kinase kinase 8 |
---|
Ligand | BDBM50264865 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_496717 (CHEMBL1005354) |
---|
IC50 | 40±n/a nM |
---|
Citation | George, D; Friedman, M; Allen, H; Argiriadi, M; Barberis, C; Bischoff, A; Clabbers, A; Cusack, K; Dixon, R; Fix-Stenzel, S; Gordon, T; Janssen, B; Jia, Y; Moskey, M; Quinn, C; Salmeron, JA; Wishart, N; Woller, K; Yu, Z Discovery of thieno[2,3-c]pyridines as potent COT inhibitors. Bioorg Med Chem Lett18:4952-5 (2008) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Mitogen-activated protein kinase kinase kinase 8 |
---|
Name: | Mitogen-activated protein kinase kinase kinase 8 |
Synonyms: | C-COT | COT | COT proto-oncogene serine/threonine-protein kinase | Cancer Osaka thyroid oncogene | ESTF | M3K8_HUMAN | MAP3K8 | Tpl-2 | Tumor Progression Loci-2 Kinase (COT) | Tumor progression locus 2 |
Type: | Serine/threonine-protein kinase |
Mol. Mass.: | 52916.89 |
Organism: | Homo sapiens (Human) |
Description: | P41279 |
Residue: | 467 |
Sequence: | MEYMSTGSDNKEEIDLLIKHLNVSDVIDIMENLYASEEPAVYEPSLMTMCQDSNQNDERS
KSLLLSGQEVPWLSSVRYGTVEDLLAFANHISNTAKHFYGQRPQESGILLNMVITPQNGR
YQIDSDVLLIPWKLTYRNIGSDFIPRGAFGKVYLAQDIKTKKRMACKLIPVDQFKPSDVE
IQACFRHENIAELYGAVLWGETVHLFMEAGEGGSVLEKLESCGPMREFEIIWVTKHVLKG
LDFLHSKKVIHHDIKPSNIVFMSTKAVLVDFGLSVQMTEDVYFPKDLRGTEIYMSPEVIL
CRGHSTKADIYSLGATLIHMQTGTPPWVKRYPRSAYPSYLYIIHKQAPPLEDIADDCSPG
MRELIEASLERNPNHRPRAADLLKHEALNPPREDQPRCQSLDSALLERKRLLSRKELELP
ENIADSSCTGSTEESEMLKRQRSLYIDLGALAGYFNLVRGPPTLEYG
|
|
|
BDBM50264865 |
---|
n/a |
---|
Name | BDBM50264865 |
Synonyms: | (4'-(2-(2H-tetrazol-5-yl)thieno[2,3-c]pyridin-4-yloxy)biphenyl-4-yl)methanol | CHEMBL491029 |
Type | Small organic molecule |
Emp. Form. | C21H15N5O2S |
Mol. Mass. | 401.441 |
SMILES | OCc1ccc(cc1)-c1ccc(Oc2cncc3sc(cc23)-c2nnn[nH]2)cc1 |
Structure |
|